Investors Research Corp’s Qiagen QGEN Stock Holding History

Investors Research Corp’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09K	Hold	28	–	–	﹤0.01%	731
2026 Q1	$1.12K	Buy	+28	New	+$1.32K	﹤0.01%	760

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Investors Research Corp's QGEN Position: Q2 2026 in Review

Investors Research Corp held its Qiagen (QGEN) position steady in Q2 2026 at 28 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Investors Research Corp first reported a position in QGEN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.12K in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Investors Research Corp held 28 shares of Qiagen worth $1.09K as of Q2 2026.
Investors Research Corp left its Qiagen share count unchanged in Q2 2026.
Qiagen made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #731 holding.
Investors Research Corp first reported a position in Qiagen in Q1 2026 and has held it in 2 quarters since.
Investors Research Corp's Qiagen position peaked at $1.12K in Q1 2026.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.